The JSE was firmer on Tuesday, along with its global counterparts as optimism over a possible coronavirus vaccine is lifting sentiment, with investors looking past simmering US-China trade tension.

On Monday, US biotech firm Novavax said that it has started the first human study of its experimental coronavirus vaccine. The firm said it expects initial results on safety and immune responses in July...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.